Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer (PRIME)

Charité University Medicine Berlin

Status: Enrolling

Conditions: Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05926284

3000764

Details and patient eligibility

About

Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• advanced cancer
• ability to give written informed consent
• performance status allows initiation of a potential targeted treatment after molecular analysis
• molecular analysis has been done or planned

Exclusion criteria

• unable to give written informed consent